Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA; Infectious Disease Service, Department of Medicine, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
J Mol Biol. 2019 Oct 4;431(21):4229-4246. doi: 10.1016/j.jmb.2019.03.027. Epub 2019 Apr 4.
The genus Aspergillus is ubiquitous in the environment and contains a number of species, primarily A. fumigatus, that cause mold-associated disease in humans. Humans inhale several hundred to several thousand Aspergillus conidia (i.e., vegetative spores) daily and typically clear these in an asymptomatic manner. In immunocompromised individuals, Aspergillus conidia can germinate into tissue-invasive hyphae, disseminate, and cause invasive aspergillosis. In this review, we first discuss novel concepts in host defense against Aspergillus infections and emphasize new insights in fungal recognition and signaling, innate immune activation, and fungal killing. Second, the review focuses on novel concepts of Aspergillus pathogenesis and highlights emerging knowledge regarding fungal strain heterogeneity, stress responses, and metabolic adaptations on infectious outcomes. Mechanistic insight into the host-pathogen interplay is thus critical to define novel druggable fungal targets and to exploit novel immune-based strategies to improve clinical outcomes associated with aspergillosis in vulnerable patient populations.
曲霉菌属在环境中无处不在,包含许多种,主要是烟曲霉,会导致人类的霉菌相关性疾病。人类每天会吸入几百到几千个曲霉菌分生孢子(即营养孢子),通常无症状清除。在免疫功能低下的个体中,曲霉菌分生孢子可以发芽成组织侵袭性菌丝,扩散并引起侵袭性曲霉病。在这篇综述中,我们首先讨论了宿主对抗曲霉菌感染的防御的新概念,并强调了真菌识别和信号转导、固有免疫激活和真菌杀伤方面的新见解。其次,综述重点介绍了曲霉菌发病机制的新概念,并强调了关于真菌株异质性、应激反应和代谢适应对感染结果的新知识。因此,深入了解宿主-病原体相互作用对于确定新的可药物靶向真菌和利用新的免疫为基础的策略来改善易患人群与曲霉病相关的临床结局至关重要。